title: Bone marrow failure in children.
abstract: Bone marrow failure in the pediatric patient places the hematologist at the junction of clinical medicine, cellular biology, and molecular genetics. The pathophysiology of these disorders is rapidly being elucidated in many laboratories. Treatments such as bone marrow transplantation and the nascent modality of gene therapy are firmly grounded in these modern sciences. This year's progress in the understanding, diagnosis, and treatment of a wide variety of predominantly pediatric bone marrow failure states is a direct result of the union between the "laboratory bench and the patient bedside."
authors.affiliation: Jack and Lucy Clark Department of Pediatrics, Mount Sinai School of Medicine, New York, NY 10029, USA.
authors.forename: A
authors.initials: A
authors.lastname: Vlachos
authors.forename: J M
authors.initials: JM
authors.lastname: Lipton
mesh_terms: D000741:Anemia, Aplastic / Q000503:physiopathology / Q000628:therapy; D016026:Bone Marrow Transplantation; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D004476:Ectodermal Dysplasia / Q000235:genetics / Q000503:physiopathology; D005199:Fanconi Anemia / Q000503:physiopathology / Q000628:therapy; D006086:Graft vs Host Disease; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006410:Hematopoiesis; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009503:Neutropenia / Q000151:congenital / Q000628:therapy; D011994:Recombinant Proteins
chemical_list: D007166:Immunosuppressive Agents; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D003520:Cyclophosphamide